Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Bladder urothelial carcinoma		Ubiquitination	N	K164	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Uveal melanoma		Ubiquitination	N	K344	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Uterine corpus endometrial carcinoma		Ubiquitination	N	K399	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Uterine corpus endometrial carcinoma		Ubiquitination	N	K403	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K554	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Hepatocellular carcinoma		Phosphorylation	N	S757	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Skin cutaneous melanoma		Ubiquitination	N	K833	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Breast invasive carcinoma		Ubiquitination	N	K907	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Colon adenocarcinoma		Ubiquitination	N	K1181	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Renal cell carcinoma		Ubiquitination	N	K1181	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Stomach adenocarcinoma		Phosphorylation	N	T1298	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Stomach adenocarcinoma		Phosphorylation	N	S1301	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Adrenocortical carcinoma		Phosphorylation	N	S1410	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Stomach adenocarcinoma		Phosphorylation	N	S1410	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Stomach adenocarcinoma		Ubiquitination	N	K1493	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Colon adenocarcinoma		Ubiquitination	N	K1716	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Kidney renal clear cell carcinoma		Ubiquitination	N	K1716	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Gray platelet syndrome		Ubiquitination	N	K1828	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Head and neck squamous cell carcinoma		Ubiquitination	N	K1828	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Lung adenocarcinoma		Ubiquitination	N	K1828	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Gray platelet syndrome		Phosphorylation	N	S1831	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Gray platelet syndrome		Phosphorylation	N	Y1835	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Gray platelet syndrome		Ubiquitination	N	K1841	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Lung squamous cell carcinoma		Phosphorylation	N	T2009	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Lung squamous cell carcinoma		Phosphorylation	N	S2012	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Lung squamous cell carcinoma		Phosphorylation	N	S2013	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Bladder urothelial carcinoma		Ubiquitination	N	K2067	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K2124	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Skin cutaneous melanoma		Ubiquitination	N	K2153	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Hepatocellular carcinoma		Phosphorylation	N	S2208	
Q6ZNJ1	23218	NBEAL2 KIAA0540 UNQ253/PRO290	Stomach adenocarcinoma		Ubiquitination	N	K2321